Effect of Medical Management and Residual Fragments on Recurrent Stone Formation Following Shock Wave Lithotripsy

Joshua K. Fine, Charles Y C Pak, Glenn M. Preminger, Joseph W. Segura, Michael Marberger

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Minimal emphasis has been placed on the clinical sequelae of residual stone fragments following shock wave lithotripsy. Moreover, there are no studies investigating the role of medical therapy on the course of stone disease in patients with residual fragments. In this retrospective, nonrandomized review, we evaluated 80 patients who had undergone shock wave lithotripsy at various institutions in Texas and were referred to our mineral metabolism clinic for metabolic evaluation and medical management of the stone disease. Of the patients 31 were determined to be stone-free following lithotripsy, while 49 had residual stone fragments. All patients were contacted an average of 43.2 months (range 9 to 79) following shock wave lithotripsy and the radiographs were reviewed. Patients were placed into 4 groups after shock wave lithotripsy: stone-free or residual fragments on or off medical therapy. In the stone-free group (19 patients), medical treatment produced a significant decrease in stone formation from a median of 0.67 to 0.0 stones per patient per year (p <0.001). In 36 patients with residual fragments stone formation before shock wave lithotripsy was higher than in the stone-free group but there was also a significant decrease in the stone formation rate from a median of 2.47 to 0.00 stones per patient per year while on medical therapy (p <0.001). Of the 12 stone-free patients who did not remain on medical therapy there was a slight decrease in the stone formation rate from a mean of 0.83 to 0.40 stones per patient per year, although this decrease was not significant (p = 0.07). In 13 patients with residual fragments not on medical treatment there was only a minimal decrease in the stone formation rate from a median of 1.33 to 0.77 stones per patient per year (p = 0.06). We also assessed the significance of so-called clinically insignificant residual fragments (smaller than 5 mm.) following shock wave lithotripsy in 26 of the 36 patients with residual fragments. More than half of the 26 patients with clinically insignificant fragments in the group that did not continue on medical therapy demonstrated significant stone growth during followup, suggesting that these fragments were not insignificant. Moreover, only 16% of the patients with fragments smaller than 5 mm. demonstrated an increase in fragment size while on medical therapy, again suggesting that appropriate medical treatment can decrease the risk of recurrent stone formation or growth (p <0.05). Our findings suggest that appropriate medical therapy may control active stone formation in patients with or without residual stone fragments following shock wave lithotripsy. Moreover, residual fragments after shock wave lithotripsy place patients at higher risk for recurrent stone formation or growth.

Original languageEnglish (US)
Pages (from-to)27-33
Number of pages7
JournalThe Journal of urology
Volume153
Issue number1
DOIs
StatePublished - 1995

Fingerprint

Lithotripsy
Therapeutics
Growth

ASJC Scopus subject areas

  • Urology

Cite this

Effect of Medical Management and Residual Fragments on Recurrent Stone Formation Following Shock Wave Lithotripsy. / Fine, Joshua K.; Pak, Charles Y C; Preminger, Glenn M.; Segura, Joseph W.; Marberger, Michael.

In: The Journal of urology, Vol. 153, No. 1, 1995, p. 27-33.

Research output: Contribution to journalArticle

Fine, Joshua K. ; Pak, Charles Y C ; Preminger, Glenn M. ; Segura, Joseph W. ; Marberger, Michael. / Effect of Medical Management and Residual Fragments on Recurrent Stone Formation Following Shock Wave Lithotripsy. In: The Journal of urology. 1995 ; Vol. 153, No. 1. pp. 27-33.
@article{81d225f72cc04463a48d90ccb17c23d0,
title = "Effect of Medical Management and Residual Fragments on Recurrent Stone Formation Following Shock Wave Lithotripsy",
abstract = "Minimal emphasis has been placed on the clinical sequelae of residual stone fragments following shock wave lithotripsy. Moreover, there are no studies investigating the role of medical therapy on the course of stone disease in patients with residual fragments. In this retrospective, nonrandomized review, we evaluated 80 patients who had undergone shock wave lithotripsy at various institutions in Texas and were referred to our mineral metabolism clinic for metabolic evaluation and medical management of the stone disease. Of the patients 31 were determined to be stone-free following lithotripsy, while 49 had residual stone fragments. All patients were contacted an average of 43.2 months (range 9 to 79) following shock wave lithotripsy and the radiographs were reviewed. Patients were placed into 4 groups after shock wave lithotripsy: stone-free or residual fragments on or off medical therapy. In the stone-free group (19 patients), medical treatment produced a significant decrease in stone formation from a median of 0.67 to 0.0 stones per patient per year (p <0.001). In 36 patients with residual fragments stone formation before shock wave lithotripsy was higher than in the stone-free group but there was also a significant decrease in the stone formation rate from a median of 2.47 to 0.00 stones per patient per year while on medical therapy (p <0.001). Of the 12 stone-free patients who did not remain on medical therapy there was a slight decrease in the stone formation rate from a mean of 0.83 to 0.40 stones per patient per year, although this decrease was not significant (p = 0.07). In 13 patients with residual fragments not on medical treatment there was only a minimal decrease in the stone formation rate from a median of 1.33 to 0.77 stones per patient per year (p = 0.06). We also assessed the significance of so-called clinically insignificant residual fragments (smaller than 5 mm.) following shock wave lithotripsy in 26 of the 36 patients with residual fragments. More than half of the 26 patients with clinically insignificant fragments in the group that did not continue on medical therapy demonstrated significant stone growth during followup, suggesting that these fragments were not insignificant. Moreover, only 16{\%} of the patients with fragments smaller than 5 mm. demonstrated an increase in fragment size while on medical therapy, again suggesting that appropriate medical treatment can decrease the risk of recurrent stone formation or growth (p <0.05). Our findings suggest that appropriate medical therapy may control active stone formation in patients with or without residual stone fragments following shock wave lithotripsy. Moreover, residual fragments after shock wave lithotripsy place patients at higher risk for recurrent stone formation or growth.",
author = "Fine, {Joshua K.} and Pak, {Charles Y C} and Preminger, {Glenn M.} and Segura, {Joseph W.} and Michael Marberger",
year = "1995",
doi = "10.1097/00005392-199501000-00010",
language = "English (US)",
volume = "153",
pages = "27--33",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Effect of Medical Management and Residual Fragments on Recurrent Stone Formation Following Shock Wave Lithotripsy

AU - Fine, Joshua K.

AU - Pak, Charles Y C

AU - Preminger, Glenn M.

AU - Segura, Joseph W.

AU - Marberger, Michael

PY - 1995

Y1 - 1995

N2 - Minimal emphasis has been placed on the clinical sequelae of residual stone fragments following shock wave lithotripsy. Moreover, there are no studies investigating the role of medical therapy on the course of stone disease in patients with residual fragments. In this retrospective, nonrandomized review, we evaluated 80 patients who had undergone shock wave lithotripsy at various institutions in Texas and were referred to our mineral metabolism clinic for metabolic evaluation and medical management of the stone disease. Of the patients 31 were determined to be stone-free following lithotripsy, while 49 had residual stone fragments. All patients were contacted an average of 43.2 months (range 9 to 79) following shock wave lithotripsy and the radiographs were reviewed. Patients were placed into 4 groups after shock wave lithotripsy: stone-free or residual fragments on or off medical therapy. In the stone-free group (19 patients), medical treatment produced a significant decrease in stone formation from a median of 0.67 to 0.0 stones per patient per year (p <0.001). In 36 patients with residual fragments stone formation before shock wave lithotripsy was higher than in the stone-free group but there was also a significant decrease in the stone formation rate from a median of 2.47 to 0.00 stones per patient per year while on medical therapy (p <0.001). Of the 12 stone-free patients who did not remain on medical therapy there was a slight decrease in the stone formation rate from a mean of 0.83 to 0.40 stones per patient per year, although this decrease was not significant (p = 0.07). In 13 patients with residual fragments not on medical treatment there was only a minimal decrease in the stone formation rate from a median of 1.33 to 0.77 stones per patient per year (p = 0.06). We also assessed the significance of so-called clinically insignificant residual fragments (smaller than 5 mm.) following shock wave lithotripsy in 26 of the 36 patients with residual fragments. More than half of the 26 patients with clinically insignificant fragments in the group that did not continue on medical therapy demonstrated significant stone growth during followup, suggesting that these fragments were not insignificant. Moreover, only 16% of the patients with fragments smaller than 5 mm. demonstrated an increase in fragment size while on medical therapy, again suggesting that appropriate medical treatment can decrease the risk of recurrent stone formation or growth (p <0.05). Our findings suggest that appropriate medical therapy may control active stone formation in patients with or without residual stone fragments following shock wave lithotripsy. Moreover, residual fragments after shock wave lithotripsy place patients at higher risk for recurrent stone formation or growth.

AB - Minimal emphasis has been placed on the clinical sequelae of residual stone fragments following shock wave lithotripsy. Moreover, there are no studies investigating the role of medical therapy on the course of stone disease in patients with residual fragments. In this retrospective, nonrandomized review, we evaluated 80 patients who had undergone shock wave lithotripsy at various institutions in Texas and were referred to our mineral metabolism clinic for metabolic evaluation and medical management of the stone disease. Of the patients 31 were determined to be stone-free following lithotripsy, while 49 had residual stone fragments. All patients were contacted an average of 43.2 months (range 9 to 79) following shock wave lithotripsy and the radiographs were reviewed. Patients were placed into 4 groups after shock wave lithotripsy: stone-free or residual fragments on or off medical therapy. In the stone-free group (19 patients), medical treatment produced a significant decrease in stone formation from a median of 0.67 to 0.0 stones per patient per year (p <0.001). In 36 patients with residual fragments stone formation before shock wave lithotripsy was higher than in the stone-free group but there was also a significant decrease in the stone formation rate from a median of 2.47 to 0.00 stones per patient per year while on medical therapy (p <0.001). Of the 12 stone-free patients who did not remain on medical therapy there was a slight decrease in the stone formation rate from a mean of 0.83 to 0.40 stones per patient per year, although this decrease was not significant (p = 0.07). In 13 patients with residual fragments not on medical treatment there was only a minimal decrease in the stone formation rate from a median of 1.33 to 0.77 stones per patient per year (p = 0.06). We also assessed the significance of so-called clinically insignificant residual fragments (smaller than 5 mm.) following shock wave lithotripsy in 26 of the 36 patients with residual fragments. More than half of the 26 patients with clinically insignificant fragments in the group that did not continue on medical therapy demonstrated significant stone growth during followup, suggesting that these fragments were not insignificant. Moreover, only 16% of the patients with fragments smaller than 5 mm. demonstrated an increase in fragment size while on medical therapy, again suggesting that appropriate medical treatment can decrease the risk of recurrent stone formation or growth (p <0.05). Our findings suggest that appropriate medical therapy may control active stone formation in patients with or without residual stone fragments following shock wave lithotripsy. Moreover, residual fragments after shock wave lithotripsy place patients at higher risk for recurrent stone formation or growth.

UR - http://www.scopus.com/inward/record.url?scp=0028970389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028970389&partnerID=8YFLogxK

U2 - 10.1097/00005392-199501000-00010

DO - 10.1097/00005392-199501000-00010

M3 - Article

VL - 153

SP - 27

EP - 33

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -